AML - ACUTE MYELOID LEUKEMIA
Clinical trials for AML - ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new AML - ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for AML - ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double stem cell transplant shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It combines stem cells from a half-matched donor (haploidentical) with cord blood, given at different times. The goal is to help the b…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
New hope for tough blood cancers? early trial of CBX-250 begins
Disease control Recruiting nowThis early-stage study tests a new drug, CBX-250, in people with certain types of blood cancers (myeloid leukemias) that have returned or not responded to standard treatments. The main goals are to find a safe dose and see how well people tolerate the drug. About 72 participants …
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:41 UTC
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control Recruiting nowThis early-stage trial tests a new cell therapy called BSB-2002 in adults with a specific form of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can prevent the cance…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New drug aims to keep leukemia away after transplant
Disease control Recruiting nowThis study tests whether a drug called chidamide can help prevent acute myeloid leukemia (AML) from coming back after a stem cell transplant. About 134 adults with high-risk AML who are in remission after transplant will either receive chidamide or be observed. The goal is to see…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug cocktail shows promise for untreated leukemia patients
Disease control Recruiting nowThis study tests a combination of five drugs (venetoclax, azacitidine, cytarabine, idarubicin, and G-CSF) as a first treatment for adults aged 18-70 with acute myeloid leukemia who are healthy enough for strong chemotherapy. The goal is to see how many patients achieve complete r…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New study checks cancer Drug's impact on common medications
Knowledge-focused Recruiting nowThis study looks at how the cancer drug olutasidenib changes the way the body processes other medications. Researchers will give a mix of test drugs to 16 adults with IDH1-mutated cancers (like AML or certain brain tumors) and measure their levels in the blood before and after ol…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Phase: PHASE4 • Sponsor: Rigel Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 10:49 UTC
-
Smartwatches could help doctors personalize blood transfusions for cancer patients
Knowledge-focused Recruiting nowThis study is for 80 adults with blood cancers like MDS or AML who are starting treatment. Participants wear a smartwatch and answer questionnaires to track their activity, symptoms, and quality of life. The goal is to help doctors better understand when patients need blood trans…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated May 26, 2026 10:45 UTC
-
Mice with human AML cells could speed up cancer drug discovery
Knowledge-focused Recruiting nowThis study aims to develop a faster way to test new drug combinations for acute myeloid leukemia (AML). Researchers will take blood and bone marrow samples from 25 AML patients and grow their cancer cells in special mice. They will then test how well standard treatments work in t…
Matched conditions: AML - ACUTE MYELOID LEUKEMIA
Sponsor: Clinical Hub for Interventional Research (CHOIR) • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC